Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psoriatic arthritis
psoriatic arthritis
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
BioSpace
Fri, 06/14/19 - 06:23 pm
JNJ
Janssen
clinical trials
Tremfya
psoriatic arthritis
Lilly’s Taltz scrapes win against Humira in psoriatic arthritis
Pharmaforum
Fri, 06/14/19 - 06:22 pm
Eli Lilly
Taltz
AbbVie
Humira
psoriatic arthritis
Novartis’ Cosentyx achieves primary and secondary endpoints in psoriatic arthritis study
Pharmaceutical Business Review
Wed, 06/12/19 - 09:57 am
Novartis
Cosentyx
clinical trials
psoriatic arthritis
AbbVie's immunology blockbuster-to-be Skyrizi picks up first global approval
Fierce Pharma
Tue, 03/26/19 - 11:04 pm
AbbVie
Japan
Skyrizi
psoriasis
psoriatic arthritis
Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial
Reuters
Mon, 12/17/18 - 08:15 pm
Eli Lilly
psoriatic arthritis
Taltz
AbbVie
Humira
clinical trials
Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update
Fierce Pharma
Thu, 06/21/18 - 11:57 am
Novartis
Cosentyx
psoriatic arthritis
Gilead, Galapagos hit goal in psoriatic arthritis phase 2
Fierce Biotech
Thu, 05/31/18 - 09:33 am
Gilead Sciences
Galapagos
filgotinib
psoriatic arthritis
clinical trials
ulcerative colitis
Pfizer takes on Novartis, Lilly with Xeljanz psoriatic arthritis approval
Fierce Pharma
Fri, 12/15/17 - 11:27 pm
Pfizer
Novartis
Eli Lilly
Xeljanz
psoriatic arthritis
Lilly's Taltz takes Cosentyx rivalry into psoriatic arthritis with new FDA nod
Fierce Pharma
Tue, 12/5/17 - 09:30 am
Eli Lilly
Taltz
Novartis
Cosentyx
FDA
psoriatic arthritis
Novartis strengthens autoimmune indications for Cosentyx
PM Live
Fri, 11/10/17 - 10:21 pm
Novartis
Cosentyx
autoimmune disease
psoriatic arthritis
ankylosing spondylitis
In Novartis' newest Cosentyx push, active, real-life patients take center stage
Fierce Pharma
Mon, 10/9/17 - 10:54 am
Novartis
Cosentyx
drug ads
psoriatic arthritis
Novartis' Cosentyx racks up more long-term data in psoriatic arthritis and ankylosing spondylitis
Fierce Pharma
Thu, 06/15/17 - 05:36 pm
Novartis
Cosentyx
psoriatic arthritis
ankylosing spondylitis
Drug Makers Target Psoriatic Arthritis
Investopedia
Thu, 11/17/16 - 04:44 pm
psoriatic arthritis
Novartis
Celgene
Otezla
Cosentyx
Pfizer reports positive results from late-stage trial of psoriatic arthritis drug
Marketwatch
Tue, 04/5/16 - 10:19 pm
Pfizer
clinical trials
psoriatic arthritis
Broaden
Novartis' psoriasis mega-blockbuster hopeful Cosentyx nabs 2 new indications
BioPharma Dive
Tue, 01/19/16 - 10:41 am
Novartis
Cosentyx
psoriasis
psoriatic arthritis
ankylosing spondylitis
Novartis’s Cosentyx: Europe’s First IL-17A Inhibitor for Some Uses
Yahoo/Market Realist
Sun, 11/29/15 - 12:27 pm
Novartis
Cosentyx
Europe
ankylosing spondylitis
psoriatic arthritis
Novartis wins European recs for a pair of new Cosentyx uses
Fierce Pharma
Fri, 10/23/15 - 11:09 am
Novartis
Europe
Cosentyx
psoriatic arthritis
ankylosing spondylitis
Lilly's psoriatic arthritis drug succeeds in late-stage study
Yahoo/Reuters
Mon, 04/20/15 - 10:35 am
Eli Lilly
psoriatic arthritis
ixekizumab
EU Oks new Celgene pill for psoriasis, psoriatic arthritis
Yahoo/AP
Sat, 01/17/15 - 10:42 am
Celgene
psoriasis
psoriatic arthritis
Here’s What Cosentyx’s Approval In Japan Means For Novartis
Bidness Etc.
Mon, 12/29/14 - 10:57 am
Cosentyx
Japan
drug approvals
Novartis
psoriatic arthritis
Pages
« first
‹ previous
1
2
3
4
next ›
last »